PPARG and Hepatic steatosis: As reported previously15, Ad-PPARγ2 injection produced severe hepatic steatosis (Fig. 4b; oil-red-O staining shown in Supplementary Fig. S1) with higher levels of hepatic TG than control Ad-GFP mice (Fig. 4c).